In contrast, the proportion of CD8 T cells expressing SLAMF3, SLAMF5 or SLAMF7 was significantly lower in the lupus patients in clinical remission compared with the other two groups (Fig. 1A). Here, LY9 is linked to systemic lupus erythematosus.